IPP Bureau
Biocon Biologics announces USFDA approval for Jobevne biosimilar Bevacizumab
By IPP Bureau - April 11, 2025
Jobevne is a vascular endothelial growth factor (VEGF) inhibitor that binds with VEGF and blocks the interaction with its receptors to prevent angiogenesis
OneSource secures GMP approval from Brazil for its flagship facility in Bengaluru
By IPP Bureau - April 11, 2025
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
US court lifts launch restrictions on Sun Pharma's autoimmune drug
By IPP Bureau - April 11, 2025
Sun Pharma has been involved in a patent infringement case with Incyte Corporation over LEQSELVI
Orchid Pharma to settle disputes with DBS Bank
By IPP Bureau - April 11, 2025
The company has entered into above Memo to settle, compromise and finally and forever resolve all disputes
Zeon Lifesciences appoints GK Sharma as Group Technical Director
By IPP Bureau - April 11, 2025
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Granules India completes acquisition of Senn Chemicals
By IPP Bureau - April 11, 2025
Strengthening capabilities in Peptide Therapeutics and CDMO services
Sanofi India MD Rodolfo Hrosz to step down on April 30
By IPP Bureau - April 11, 2025
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
Shilpa Medicare receives US approval for Varenicline Tablets, 0.5 mg and 1 mg
By IPP Bureau - April 10, 2025
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
By IPP Bureau - April 10, 2025
Data highlight ambition to transform prevention and treatment for serious bacterial infections and develop novel preventative strategies for respiratory viral infections
Shilpa’s Unit-2 passes second consecutive FDA inspection with no 483s
By IPP Bureau - April 09, 2025
Raichur site is the group’s largest API facility and part of a wider network of seven sites
ZIM Laboratories and Globalpharma collaborate to commercialize oral thin film products in GCC
By IPP Bureau - April 09, 2025
This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
CuraTeQ Biologics completes Phase 1 Pharmacokinetics study of biosimilar Denosumab
By IPP Bureau - April 09, 2025
This study enrolled a total of 204 healthy volunteers into three groups to compare BP16 with the reference products, Prolia, obtained from both the EU and US markets
Honeywell launches AI-assisted automation platform for life sciences manufacturing industry
By IPP Bureau - April 08, 2025
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Anurag Mantri appointed as President of Glenmark Pharmaceuticals
By IPP Bureau - April 08, 2025
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
Asahi Kasei establishes Asahi Kasei Life Science to drive its bioprocess businesses
By IPP Bureau - April 08, 2025
Asahi Kasei Life Science covers a broad range of bioprocess products and services
